日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
NEC With Chugai Use AI to Speed Cancer Drug Predictions
NEC Corporation and Chugai Pharmaceutical Co., Ltd. worked together on an AI…
LPIXEL Inc and MNES Launch AI Plan for Medical Imaging
LPIXEL Inc. has announced a new integrated plan that connects its image…
Sapeet Inc Adds AI Features to Yucari Amerge for Hospitals
Sapeet Inc. was in charge of the design, development, and implementation of…
Freee And Saiseikai Kumamoto Partner on Hospital Tools
Freee Corporation and Onshi Foundation Saiseikai Kumamoto Hospital, a social welfare corporation,…
SDP Japan Inc Secures $31M in Series D Funding Round
SDP Japan has raised around $31 million (JPY 4.5 billion) in its…
HekaBio And Alfresa Form Strategic Biopharma Partnership
HekaBio K.K. is a biopharma and MedTech platform in Japan. It has…
Infocom Unveils DigiPro EPPV for Early Drug Monitoring
Infocom Corporation is pleased to announce that it has begun offering "DigiPro…
Cardio Diagnostics Inc Gets Japan Patent for AI Heart Tech
Cardio Diagnostics Holdings Inc., an artificial intelligence-powered precision cardiovascular medicine company, announced…
Latest Article
English